FDA approves first new antibiotic for UTIs in nearly 30 years
The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...
US FDA greenlights GSK's drug for UTIs in women and girls
The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...
GSK studying if best-selling shingles vaccine lowers dementia risk
GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...
‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has transformed the pharma giant into a tech powerhouse
For GSK’s Ramakrishnan, who has served as CDTO since 2021, the biggest challenge was helping her company get a head start in ...
US FDA approves GSK's urinary tract infection drug
The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...
FDA approves a new kind of oral antibiotic to treat urinary tract infections
The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...
23andMe thought its DNA data would help research. Then reality hit.
The company saw its DNA data as an engine that would revolutionize drug discovery and medical care, but it never found a ...
There’s a New Pill to Treat UTIs
On March 25, the U.S. Food and Drug Administration (FDA) approved the first new antibiotic to treat UTIs in 30 years. The ...
GlobalData on MSN7h
GSK and UK researchers plan to study Shingrix and dementia risk reduction link
The study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).
GlobalData on MSN16h
EMA to review GSK’s Nucala for COPD treatment expansion
GSK’s application is underpinned by the positive outcomes from the Phase III MATINEE trial, which demonstrated a significant ...
BioSpace13h
GSK Builds on Real-World Experiment to Study Shingrix’s Impact on Dementia
The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” ...
Business Recorder1h
Freshwater ecosystems in South Asia: WWF, GSK announce multi-million-pound partnership
KARACHI: In a groundbreaking initiative to combat water stress and safeguard biodiversity, the World Wide Fund ...